eHealth Financial Statements (EHTH)
|
|
|
|
Report date
|
|
|
01.03.2023 |
31.12.2023 |
29.02.2024 |
27.02.2025 |
26.02.2026 |
|
07.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
405.4 |
452.9 |
452.9 |
532.4 |
554.0 |
|
556.1 |
|
Operating Income, bln rub |
|
|
-102.7 |
-29.1 |
-29.1 |
23.6 |
68.5 |
|
79.0 |
|
EBITDA, bln rub |
? |
|
-77.7 |
-9.16 |
0.295 |
46.8 |
83.2 |
|
85.4 |
|
Net profit, bln rub |
? |
|
-88.7 |
-28.2 |
-28.2 |
10.1 |
40.0 |
|
19.3 |
|
|
OCF, bln rub |
? |
|
-26.9 |
-6.69 |
-6.69 |
-18.4 |
-25.3 |
|
10.3 |
|
CAPEX, bln rub |
? |
|
15.5 |
10.8 |
10.8 |
12.9 |
2.25 |
|
3.77 |
|
FCF, bln rub |
? |
|
-42.4 |
-17.5 |
-17.5 |
-31.2 |
-27.6 |
|
6.65 |
|
Dividend payout, bln rub
|
|
|
0.000 |
3.53 |
0.000 |
5.56 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
55.3% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
506.4 |
460.3 |
480.2 |
507.0 |
471.8 |
|
396.6 |
|
Cost of production, bln rub |
|
|
1.65 |
21.7 |
1.77 |
1.79 |
13.8 |
|
3.21 |
|
R&D, bln rub |
|
|
0.000 |
61.0 |
0.000 |
0.000 |
51.8 |
|
30.6 |
|
Interest expenses, bln rub |
|
|
7.63 |
11.0 |
11.0 |
11.2 |
10.8 |
|
13.8 |
|
|
Assets, bln rub |
|
|
1 113 |
1 113 |
1 113 |
1 155 |
1 262 |
|
1 201 |
|
Net Assets, bln rub |
? |
|
651.0 |
904.1 |
904.1 |
588.4 |
973.7 |
|
575.7 |
|
Debt, bln rub |
|
|
106.8 |
103.2 |
103.2 |
96.9 |
134.4 |
|
133.2 |
|
Cash, bln rub |
|
|
144.4 |
121.7 |
121.7 |
82.2 |
77.2 |
|
110.8 |
|
Net debt, bln rub |
|
|
-37.6 |
-18.5 |
-18.5 |
14.7 |
57.1 |
|
22.4 |
|
|
Ordinary share price, rub |
|
|
4.84 |
8.72 |
8.72 |
9.40 |
4.60 |
|
1.86 |
|
Number of ordinary shares, mln |
|
|
27.4 |
28.0 |
28.0 |
29.3 |
30.5 |
|
0.000 |
|
|
Market cap, bln rub |
|
|
132 |
244 |
244 |
276 |
140 |
|
0 |
|
EV, bln rub |
? |
|
95 |
226 |
226 |
290 |
197 |
|
22 |
|
Book value, bln rub |
|
|
651 |
904 |
880 |
588 |
951 |
|
576 |
|
|
EPS, rub |
? |
|
-3.24 |
-1.01 |
-1.01 |
0.34 |
1.31 |
|
|
|
FCF/share, rub |
|
|
-1.55 |
-0.62 |
-0.62 |
-1.06 |
-0.91 |
|
|
|
BV/share, rub |
|
|
23.8 |
32.3 |
31.4 |
20.1 |
31.2 |
|
|
|
|
EBITDA margin, % |
? |
|
-19.2% |
-2.02% |
0.07% |
8.79% |
15.0% |
|
15.4% |
|
Net margin, % |
? |
|
-21.9% |
-6.23% |
-6.23% |
1.89% |
7.23% |
|
3.47% |
|
FCF yield, % |
? |
|
-32.0% |
-7.15% |
-7.15% |
-11.3% |
-19.7% |
|
0.00% |
|
ROE, % |
? |
|
-13.6% |
-3.12% |
-3.12% |
1.71% |
4.11% |
|
3.35% |
|
ROA, % |
? |
|
-7.97% |
-2.53% |
-2.53% |
0.87% |
3.17% |
|
1.61% |
|
|
P/E |
? |
|
-1.49 |
-8.66 |
-8.66 |
27.4 |
3.50 |
|
0.00 |
|
P/FCF |
|
|
-3.12 |
-14.0 |
-14.0 |
-8.83 |
-5.08 |
|
0.00 |
|
P/S |
? |
|
0.33 |
0.54 |
0.54 |
0.52 |
0.25 |
|
0.00 |
|
P/BV |
? |
|
0.20 |
0.27 |
0.28 |
0.47 |
0.15 |
|
0.00 |
|
EV/EBITDA |
? |
|
-1.22 |
-24.7 |
765.4 |
6.20 |
2.37 |
|
0.26 |
|
Debt/EBITDA |
|
|
0.48 |
2.02 |
-62.7 |
0.31 |
0.69 |
|
0.26 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
566.2% |
0.00% |
0.00% |
2 304% |
|
811.4% |
|
|
CAPEX/Revenue, % |
|
|
3.83% |
2.38% |
2.38% |
2.41% |
0.41% |
|
0.68% |
|
| eHealth shareholders |
